<DOC>
	<DOCNO>NCT01446198</DOCNO>
	<brief_summary>The objective establish APTIMA HPV Assay performance PANTHER System comparable performance TIGRIS System .</brief_summary>
	<brief_title>Clinical Evaluation APTIMA® HPV Assay Using PANTHER™ System</brief_title>
	<detailed_description>The APTIMA HPV Assay vitro nucleic acid amplification test qualitative detection E6/E7 viral messenger RNA ( mRNA ) 14 high-risk type human papillomavirus ( HPV ) cervical specimen . The high-risk HPV type detect assay include : 16 , 18 , 31 , 33 , 35 , 39 , 45 , 51 , 52 , 56 , 58 , 59 , 66 , 68 . The APTIMA HPV Assay discriminate 14 high-risk type . Cervical specimen collect ThinPrep Pap Test vial contain PreservCyt® Solution commercially available collection device ( broom-type device cytobrush/spatula combination ) may test APTIMA HPV Assay either pre- post-Pap processing . The assay use TIGRIS System PANTHER System . The objective establish APTIMA HPV Assay performance PANTHER System comparable performance TIGRIS System .</detailed_description>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>sample aliquot valid positive negative APTIMA HPV Assay TIGRIS System result ( test protocol 2007HPVASCUS30 ) aliquot available suitable testing , sample randomly select inclusion . sample integrity compromise ( eg , store unacceptable condition )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>HPV</keyword>
</DOC>